<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02408978</url>
  </required_header>
  <id_info>
    <org_study_id>OXP005-002</org_study_id>
    <nct_id>NCT02408978</nct_id>
  </id_info>
  <brief_title>Pilot Study of OXP005 to Assess Gastroduodenal Irritation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oxford Pharmascience Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oxford Pharmascience Ltd</source>
  <brief_summary>
    <textblock>
      Oxford Pharmascience Ltd (the Sponsor) is developing a new naproxen tablet formulation (the
      study drug, OXP005), for the potential treatment of rheumatic and painful conditions. The
      study will compare the study drug to an already marketed formulation of prescription strength
      naproxen (NaprosynÂ® the reference product) by looking at the relative impact of both products
      on gastroduodenal (GD) irritation by performing a specialist procedure called an endoscopy
      (or more specifically, a gastroscopy). The safety and tolerability of the study drug will
      also be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of GD irritation in the stomach and duodenum as measured by the Lanza score</measure>
    <time_frame>Day 8</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total number of GD erosions overall</measure>
    <time_frame>Day 8</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Gastroduodenal Erosions</condition>
  <arm_group>
    <arm_group_label>OXP005</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1g naproxen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>naproxen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1g naproxen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OXP005</intervention_name>
    <arm_group_label>OXP005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen</intervention_name>
    <arm_group_label>naproxen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female subject

          -  Healthy, normal upper GI tract as indicated by no ulcers or erosions at baseline, as
             assessed by the gastroenterologist conducting the endoscopy (ie Lanza score of 0 in
             both the stomach and duodenum)

          -  H. pylori negative

        Exclusion Criteria:

          -  Clinically significant abnormal laboratory parameters

          -  Any clinically significant diseases or conditions affecting the haematopoietic,
             cardiovascular, renal, hepatic, endocrine, pulmonary, centralcnervous, immunological,
             dermatological, GI or any other body system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Mair, MBChB, DRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quotient Clinical Ltd</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Quotient Clinical Ltd</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>March 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2015</study_first_posted>
  <last_update_submitted>June 17, 2015</last_update_submitted>
  <last_update_submitted_qc>June 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naproxen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

